Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2022-05-01
|
| Series: | Liver Cancer |
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/524977 |
| _version_ | 1828724875199512576 |
|---|---|
| author | Masatoshi Kudo |
| author_facet | Masatoshi Kudo |
| author_sort | Masatoshi Kudo |
| collection | DOAJ |
| first_indexed | 2024-04-12T13:17:11Z |
| format | Article |
| id | doaj.art-3d5576991ce949f9b745b644ea0f0b5e |
| institution | Directory Open Access Journal |
| issn | 2235-1795 1664-5553 |
| language | English |
| last_indexed | 2024-04-12T13:17:11Z |
| publishDate | 2022-05-01 |
| publisher | Karger Publishers |
| record_format | Article |
| series | Liver Cancer |
| spelling | doaj.art-3d5576991ce949f9b745b644ea0f0b5e2022-12-22T03:31:39ZengKarger PublishersLiver Cancer2235-17951664-55532022-05-0111318519110.1159/000524977524977Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed SubclassMasatoshi Kudohttps://orcid.org/0000-0002-4102-3474https://www.karger.com/Article/FullText/524977hepatocellular carcinomaanti-pd-1/pd-l1 antibodyanti-vegf antibodynoninflamed tumor |
| spellingShingle | Masatoshi Kudo Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass Liver Cancer hepatocellular carcinoma anti-pd-1/pd-l1 antibody anti-vegf antibody noninflamed tumor |
| title | Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass |
| title_full | Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass |
| title_fullStr | Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass |
| title_full_unstemmed | Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass |
| title_short | Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass |
| title_sort | combination immunotherapy with anti pd 1 pd l1 antibody plus anti vegf antibody may promote cytotoxic t lymphocyte infiltration in hepatocellular carcinoma including in the noninflamed subclass |
| topic | hepatocellular carcinoma anti-pd-1/pd-l1 antibody anti-vegf antibody noninflamed tumor |
| url | https://www.karger.com/Article/FullText/524977 |
| work_keys_str_mv | AT masatoshikudo combinationimmunotherapywithantipd1pdl1antibodyplusantivegfantibodymaypromotecytotoxictlymphocyteinfiltrationinhepatocellularcarcinomaincludinginthenoninflamedsubclass |